{"transactions":[{"id":691189,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-08-11T20:38:49.000Z","date":"2026-08-10","kind":"gift","planned":false,"acquired":false,"shares":257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31041,"source":{"system":"sec-edgar","filing":"0001100682-26-000128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000128/form4.xml","form_type":"4"}},{"id":755530,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-06-02T20:40:38.000Z","date":"2026-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":235,"price":180.71,"value":42466.85,"ownership":{"direct":true},"balance_after":31298,"source":{"system":"sec-edgar","filing":"0001100682-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000097/form4.xml","form_type":"4"}},{"id":755529,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-06-02T20:40:38.000Z","date":"2026-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":744,"price":180.71,"value":134448.24,"ownership":{"direct":true},"balance_after":31533,"source":{"system":"sec-edgar","filing":"0001100682-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000097/form4.xml","form_type":"4"}},{"id":755528,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-06-02T20:40:38.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":5257,"price":180.71,"value":949992.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030."}],"balance_after":32277,"source":{"system":"sec-edgar","filing":"0001100682-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000097/form4.xml","form_type":"4"}},{"id":760594,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-05-28T20:24:53.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":185,"price":156.73,"value":28995.05,"ownership":{"direct":true},"balance_after":27020,"source":{"system":"sec-edgar","filing":"0001100682-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000075/form4.xml","form_type":"4"}},{"id":760593,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-05-28T20:24:53.000Z","date":"2026-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":243,"price":160.3,"value":38952.9,"ownership":{"direct":true},"balance_after":27205,"source":{"system":"sec-edgar","filing":"0001100682-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000075/form4.xml","form_type":"4"}},{"id":862693,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-03-04T21:39:28.000Z","date":"2026-03-03","kind":"purchase","planned":false,"acquired":true,"shares":25,"price":174.54,"value":4363.5,"ownership":{"direct":true},"balance_after":27448,"source":{"system":"sec-edgar","filing":"0001100682-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000024/form4.xml","form_type":"4"}},{"id":922578,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-02-03T21:36:02.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":1749,"price":211.68,"value":370228.32,"ownership":{"direct":true},"balance_after":27423,"source":{"system":"sec-edgar","filing":"0001100682-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000016/form4.xml","form_type":"4"}},{"id":922577,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-02-03T21:36:02.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":5456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023."}],"balance_after":29172,"source":{"system":"sec-edgar","filing":"0001100682-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000016/form4.xml","form_type":"4"}},{"id":935809,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2026-01-20T13:49:50.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":400,"price":163.72,"value":65488.0,"ownership":{"direct":true},"balance_after":23716,"source":{"system":"sec-edgar","filing":"0001100682-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000002/form4.xml","form_type":"4"}},{"id":1060609,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-08-20T20:45:35.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":800,"price":157.6,"value":126080.0,"ownership":{"direct":true},"balance_after":24116,"source":{"system":"sec-edgar","filing":"0001100682-25-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068225000036/form4.xml","form_type":"4"}},{"id":1071601,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-08-08T20:18:55.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":400,"price":150.04,"value":60016.0,"ownership":{"direct":true},"balance_after":24916,"source":{"system":"sec-edgar","filing":"0001127602-25-020282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225020282/form4.xml","form_type":"4"}},{"id":1118464,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-06-09T20:21:38.000Z","date":"2025-06-05","kind":"gift","planned":false,"acquired":false,"shares":385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25316,"source":{"system":"sec-edgar","filing":"0001127602-25-017074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225017074/form4.xml","form_type":"4"}},{"id":1125777,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-06-03T20:58:37.000Z","date":"2025-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":155,"price":135.63,"value":21022.65,"ownership":{"direct":true},"balance_after":25701,"source":{"system":"sec-edgar","filing":"0001127602-25-016553","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225016553/form4.xml","form_type":"4"}},{"id":1125776,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-06-03T20:58:37.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":6709,"price":135.63,"value":909941.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029."}],"balance_after":25856,"source":{"system":"sec-edgar","filing":"0001127602-25-016553","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225016553/form4.xml","form_type":"4"}},{"id":1130909,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-05-29T21:05:52.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":83,"price":138.65,"value":11507.95,"ownership":{"direct":true},"balance_after":19147,"source":{"system":"sec-edgar","filing":"0001127602-25-015900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015900/form4.xml","form_type":"4"}},{"id":1130908,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-05-29T21:05:52.000Z","date":"2025-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":122,"price":136.73,"value":16681.06,"ownership":{"direct":true},"balance_after":19230,"source":{"system":"sec-edgar","filing":"0001127602-25-015900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015900/form4.xml","form_type":"4"}},{"id":1130907,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-05-29T21:05:52.000Z","date":"2025-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":161,"price":136.73,"value":22013.53,"ownership":{"direct":true},"balance_after":19352,"source":{"system":"sec-edgar","filing":"0001127602-25-015900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015900/form4.xml","form_type":"4"}},{"id":1147884,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-05-15T20:38:33.000Z","date":"2025-05-13","kind":"sale","planned":false,"acquired":false,"shares":500,"price":145.41,"value":72705.0,"ownership":{"direct":true},"balance_after":19513,"source":{"system":"sec-edgar","filing":"0001127602-25-014484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225014484/form4.xml","form_type":"4"}},{"id":1253676,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-02-21T21:36:09.000Z","date":"2025-02-20","kind":"sale","planned":false,"acquired":false,"shares":4400,"price":162.5,"value":715000.0,"ownership":{"direct":true},"balance_after":20013,"source":{"system":"sec-edgar","filing":"0001127602-25-006249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225006249/form4.xml","form_type":"4"}},{"id":1287751,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-02-03T21:58:33.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":846,"price":165.57,"value":140072.22,"ownership":{"direct":true},"balance_after":24413,"source":{"system":"sec-edgar","filing":"0001127602-25-002780","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225002780/form4.xml","form_type":"4"}},{"id":1287750,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2025-02-03T21:58:33.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":2738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022."}],"balance_after":25259,"source":{"system":"sec-edgar","filing":"0001127602-25-002780","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225002780/form4.xml","form_type":"4"}},{"id":1436240,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-08-12T20:13:23.000Z","date":"2024-08-08","kind":"sale","planned":false,"acquired":false,"shares":1780,"price":199.36,"value":354860.8,"ownership":{"direct":true},"balance_after":22521,"source":{"system":"sec-edgar","filing":"0001127602-24-022003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224022003/form4.xml","form_type":"4"}},{"id":1493140,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-06-04T20:46:26.000Z","date":"2024-06-03","kind":"gift","planned":false,"acquired":false,"shares":311,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24301,"source":{"system":"sec-edgar","filing":"0001127602-24-017714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017714/form4.xml","form_type":"4"}},{"id":1495512,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-03T20:37:52.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4797,"price":208.44,"value":999886.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock options vest as follows: 1,199 on May 31, 2025,  1,199 on May 31, 2026,  1,199 on May 31, 2027, and  1,200 on May 31, 2028."}],"balance_after":4797,"derivative":{"exercise_price":208.44,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":4797},"source":{"system":"sec-edgar","filing":"0001127602-24-017309","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017309/form4.xml","form_type":"4"}},{"id":1495511,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-06-03T20:37:52.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":2111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 527 on May 31, 2025,  528 on May 31, 2026,  528 on May 31, 2027, and  528 on May 31, 2028."}],"balance_after":24612,"source":{"system":"sec-edgar","filing":"0001127602-24-017309","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017309/form4.xml","form_type":"4"}},{"id":1496953,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-05-31T20:19:43.000Z","date":"2024-05-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":223,"price":214.51,"value":47835.73,"ownership":{"direct":true},"balance_after":22501,"source":{"system":"sec-edgar","filing":"0001127602-24-017116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017116/form4.xml","form_type":"4"}},{"id":1500830,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-05-28T21:29:21.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":125,"price":217.21,"value":27151.25,"ownership":{"direct":true},"balance_after":22724,"source":{"system":"sec-edgar","filing":"0001127602-24-016726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016726/form4.xml","form_type":"4"}},{"id":1500829,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-05-28T21:29:21.000Z","date":"2024-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":217.21,"value":39966.64,"ownership":{"direct":true},"balance_after":22849,"source":{"system":"sec-edgar","filing":"0001127602-24-016726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016726/form4.xml","form_type":"4"}},{"id":1500828,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-05-28T21:29:21.000Z","date":"2024-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":243,"price":217.21,"value":52782.03,"ownership":{"direct":true},"balance_after":23033,"source":{"system":"sec-edgar","filing":"0001127602-24-016726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016726/form4.xml","form_type":"4"}},{"id":1517883,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-05-14T20:49:48.000Z","date":"2024-05-10","kind":"sale","planned":false,"acquired":false,"shares":1304,"price":226.97,"value":295968.88,"ownership":{"direct":true},"balance_after":23276,"source":{"system":"sec-edgar","filing":"0001127602-24-015276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224015276/form4.xml","form_type":"4"}},{"id":1562168,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-03-25T21:55:30.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":994,"price":220.28,"value":218958.32,"ownership":{"direct":true},"balance_after":25418,"source":{"system":"sec-edgar","filing":"0001127602-24-011098","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224011098/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-31"}},{"id":1562167,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-03-25T21:55:30.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":3279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021."}],"balance_after":26412,"source":{"system":"sec-edgar","filing":"0001127602-24-011098","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224011098/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-31"}},{"id":1634841,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-02-20T22:20:59.000Z","date":"2024-02-15","kind":"sale","planned":false,"acquired":false,"shares":838,"price":238.93,"value":200223.34,"ownership":{"direct":true},"balance_after":24620,"source":{"system":"sec-edgar","filing":"0001127602-24-005818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224005818/form4.xml","form_type":"4"}},{"id":1665541,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-01-31T22:28:33.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1025,"price":220.28,"value":225787.0,"ownership":{"direct":true},"balance_after":25458,"source":{"system":"sec-edgar","filing":"0001127602-24-002802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002802/form4.xml","form_type":"4"}},{"id":1665540,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2024-01-31T22:28:33.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021."}],"balance_after":26483,"source":{"system":"sec-edgar","filing":"0001127602-24-002802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002802/form4.xml","form_type":"4"}},{"id":1725791,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-12-01T21:10:41.000Z","date":"2023-11-30","kind":"sale","planned":false,"acquired":false,"shares":1850,"price":197.73,"value":365800.5,"ownership":{"direct":true},"balance_after":23133,"source":{"system":"sec-edgar","filing":"0001127602-23-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223028591/form4.xml","form_type":"4"}},{"id":1744430,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-11-13T21:12:19.000Z","date":"2023-11-09","kind":"exercise","planned":false,"acquired":false,"shares":9128,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":9128},"source":{"system":"sec-edgar","filing":"0001127602-23-027226","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223027226/form4.xml","form_type":"4"}},{"id":1744429,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-11-13T21:12:19.000Z","date":"2023-11-09","kind":"sale","planned":false,"acquired":false,"shares":6543,"price":173.76,"value":1136911.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $173.74 to $174.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24983,"source":{"system":"sec-edgar","filing":"0001127602-23-027226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223027226/form4.xml","form_type":"4"}},{"id":1744428,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-11-13T21:12:19.000Z","date":"2023-11-09","kind":"sale","planned":false,"acquired":false,"shares":2585,"price":172.77,"value":446610.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $172.32 to $173.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31526,"source":{"system":"sec-edgar","filing":"0001127602-23-027226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223027226/form4.xml","form_type":"4"}},{"id":1744427,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-11-13T21:12:19.000Z","date":"2023-11-09","kind":"exercise","planned":false,"acquired":true,"shares":9128,"price":144.67,"value":1320547.76,"ownership":{"direct":true},"balance_after":34111,"source":{"system":"sec-edgar","filing":"0001127602-23-027226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223027226/form4.xml","form_type":"4"}},{"id":1808870,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-08-14T20:11:01.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":700,"price":216.52,"value":151564.0,"ownership":{"direct":true},"balance_after":24983,"source":{"system":"sec-edgar","filing":"0001127602-23-022480","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223022480/form4.xml","form_type":"4"}},{"id":1873639,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-31T22:10:20.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":5252,"price":194.12,"value":1019518.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,313 on May 26, 2024, 1,313 on May 26, 2025, 1,313 on May 26, 2026 and 1,313 on May 26, 2027."}],"balance_after":5252,"derivative":{"exercise_price":194.12,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":5252},"source":{"system":"sec-edgar","filing":"0001127602-23-017254","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017254/form4.xml","form_type":"4"}},{"id":1873638,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-05-31T22:10:20.000Z","date":"2023-05-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":223,"price":194.12,"value":43288.76,"ownership":{"direct":true},"balance_after":25683,"source":{"system":"sec-edgar","filing":"0001127602-23-017254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017254/form4.xml","form_type":"4"}},{"id":1873637,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-05-31T22:10:20.000Z","date":"2023-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":125,"price":194.12,"value":24265.0,"ownership":{"direct":true},"balance_after":25906,"source":{"system":"sec-edgar","filing":"0001127602-23-017254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017254/form4.xml","form_type":"4"}},{"id":1873636,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-05-31T22:10:20.000Z","date":"2023-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":194.12,"value":35718.08,"ownership":{"direct":true},"balance_after":26031,"source":{"system":"sec-edgar","filing":"0001127602-23-017254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017254/form4.xml","form_type":"4"}},{"id":1873635,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-05-31T22:10:20.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":2189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units vest as follows: 547 on May 26, 2024, 547 on May 26, 2025, 547 on May 26, 2026 and 548 on May 26, 2027."}],"balance_after":26215,"source":{"system":"sec-edgar","filing":"0001127602-23-017254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017254/form4.xml","form_type":"4"}},{"id":1891970,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-05-16T18:18:58.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":345,"price":190.39,"value":65684.55,"ownership":{"direct":true},"balance_after":24026,"source":{"system":"sec-edgar","filing":"0001127602-23-015694","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223015694/form4.xml","form_type":"4"}},{"id":1893849,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-05-15T18:49:37.000Z","date":"2023-05-12","kind":"sale","planned":false,"acquired":false,"shares":9,"price":194.07,"value":1746.63,"ownership":{"direct":true},"balance_after":24371,"source":{"system":"sec-edgar","filing":"0001127602-23-015525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223015525/form4.xml","form_type":"4"}},{"id":1893848,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-05-15T18:49:37.000Z","date":"2023-05-12","kind":"sale","planned":false,"acquired":false,"shares":950,"price":193.02,"value":183369.0,"ownership":{"direct":true},"balance_after":24380,"source":{"system":"sec-edgar","filing":"0001127602-23-015525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223015525/form4.xml","form_type":"4"}},{"id":2000512,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-02-22T21:24:35.000Z","date":"2023-02-22","kind":"tax_withholding","acquired":false,"shares":317,"price":243.6,"value":77221.2,"ownership":{"direct":true},"balance_after":25330,"source":{"system":"sec-edgar","filing":"0001127602-23-006461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223006461/form4.xml","form_type":"4"}},{"id":2042493,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-01-30T21:39:54.000Z","date":"2023-01-27","kind":"tax_withholding","acquired":false,"shares":3261,"price":244.29,"value":796629.69,"ownership":{"direct":true},"balance_after":25647,"source":{"system":"sec-edgar","filing":"0001127602-23-002668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223002668/form4.xml","form_type":"4"}},{"id":2042492,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2023-01-30T21:39:54.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":8676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020."}],"balance_after":28908,"source":{"system":"sec-edgar","filing":"0001127602-23-002668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223002668/form4.xml","form_type":"4"}},{"id":2096678,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-12-05T21:55:14.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":6409,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":109.34,"exercise_date":"2019-02-23","expiration_date":"2023-02-23","underlying":"Common Stock","underlying_shares":6409},"source":{"system":"sec-edgar","filing":"0001127602-22-026898","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222026898/form4.xml","form_type":"4"}},{"id":2096677,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-12-05T21:55:14.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":1106,"price":224.8502,"value":248684.3212,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $224.66 to $225.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20232,"source":{"system":"sec-edgar","filing":"0001127602-22-026898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222026898/form4.xml","form_type":"4"}},{"id":2096676,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-12-05T21:55:14.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":4165,"price":224.4139,"value":934683.8935,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $223.68 to $224.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21338,"source":{"system":"sec-edgar","filing":"0001127602-22-026898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222026898/form4.xml","form_type":"4"}},{"id":2096675,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-12-05T21:55:14.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":1138,"price":223.055,"value":253836.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $222.66 to $223.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25503,"source":{"system":"sec-edgar","filing":"0001127602-22-026898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222026898/form4.xml","form_type":"4"}},{"id":2096674,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-12-05T21:55:14.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":6409,"price":109.34,"value":700760.06,"ownership":{"direct":true},"balance_after":26641,"source":{"system":"sec-edgar","filing":"0001127602-22-026898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222026898/form4.xml","form_type":"4"}},{"id":2123618,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-11-07T23:54:20.000Z","date":"2022-11-04","kind":"sale","acquired":false,"shares":534,"price":216.36,"value":115536.24,"ownership":{"direct":true},"balance_after":20232,"source":{"system":"sec-edgar","filing":"0001127602-22-025053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222025053/form4.xml","form_type":"4"}},{"id":2192146,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-08-08T19:03:52.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":200,"price":226.1341,"value":45226.82,"ownership":{"direct":true},"balance_after":20766,"source":{"system":"sec-edgar","filing":"0001127602-22-020666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222020666/form4.xml","form_type":"4"}},{"id":2192145,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-08-08T19:03:52.000Z","date":"2022-07-06","kind":"gift","acquired":false,"shares":195,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20966,"source":{"system":"sec-edgar","filing":"0001127602-22-020666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222020666/form4.xml","form_type":"4"}},{"id":2251799,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-05-31T23:09:09.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":4478,"price":244.41,"value":1094467.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,119 on May 27, 2023, 1,120 on May 27, 2024, 1,119 on May 27, 2025 and 1,120 on May 27, 2026."}],"balance_after":4478,"derivative":{"exercise_price":244.41,"exercise_date":"2023-05-27","expiration_date":"2032-05-27","underlying":"Common Stock","underlying_shares":4478},"source":{"system":"sec-edgar","filing":"0001127602-22-016066","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016066/form4.xml","form_type":"4"}},{"id":2251798,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-05-31T23:09:09.000Z","date":"2022-05-29","kind":"tax_withholding","acquired":false,"shares":223,"price":244.41,"value":54503.43,"ownership":{"direct":true},"balance_after":21161,"source":{"system":"sec-edgar","filing":"0001127602-22-016066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016066/form4.xml","form_type":"4"}},{"id":2251797,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-05-31T23:09:09.000Z","date":"2022-05-28","kind":"tax_withholding","acquired":false,"shares":125,"price":244.41,"value":30551.25,"ownership":{"direct":true},"balance_after":21384,"source":{"system":"sec-edgar","filing":"0001127602-22-016066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016066/form4.xml","form_type":"4"}},{"id":2251796,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-05-31T23:09:09.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":1657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 414 on May 27, 2023, 414 on May 27, 2024, 414 on May 27, 2025 and 415 on May 27, 2026."}],"balance_after":21509,"source":{"system":"sec-edgar","filing":"0001127602-22-016066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016066/form4.xml","form_type":"4"}},{"id":2375509,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-24T23:37:29.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":395,"price":292.75,"value":115636.25,"ownership":{"direct":true},"balance_after":19852,"source":{"system":"sec-edgar","filing":"0001127602-22-006657","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006657/form4.xml","form_type":"4"}},{"id":2379306,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":743,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":88.05,"exercise_date":"2018-02-24","expiration_date":"2022-02-24","underlying":"Common Stock","underlying_shares":743},"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2379305,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":315,"price":289.58,"value":91217.7,"ownership":{"direct":true},"balance_after":20247,"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2379304,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-22","kind":"sale","acquired":false,"shares":392,"price":290.834,"value":114006.928,"ownership":{"direct":true},"balance_after":20562,"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2379303,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-22","kind":"sale","acquired":false,"shares":4,"price":290.81,"value":1163.24,"ownership":{"direct":true},"balance_after":20954,"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2379302,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":317,"price":293.61,"value":93074.37,"ownership":{"direct":true},"balance_after":20958,"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2379301,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-18","kind":"sale","acquired":false,"shares":1143,"price":291.8,"value":333527.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $291.68 to $292.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21275,"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2379300,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":743,"price":88.05,"value":65421.15,"ownership":{"direct":true},"balance_after":22418,"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2379299,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-23T21:44:50.000Z","date":"2022-02-14","kind":"gift","acquired":false,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21675,"source":{"system":"sec-edgar","filing":"0001127602-22-006343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006343/form4.xml","form_type":"4"}},{"id":2419656,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-01T22:39:53.000Z","date":"2022-01-28","kind":"tax_withholding","acquired":false,"shares":4570,"price":312.24,"value":1426936.8,"ownership":{"direct":true},"balance_after":21825,"source":{"system":"sec-edgar","filing":"0001127602-22-002801","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002801/form4.xml","form_type":"4"}},{"id":2419655,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2022-02-01T22:39:53.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":11344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019."}],"balance_after":26395,"source":{"system":"sec-edgar","filing":"0001127602-22-002801","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002801/form4.xml","form_type":"4"}},{"id":2458780,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-12-27T20:43:55.000Z","date":"2021-12-25","kind":"grant","acquired":true,"shares":6771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 6,771 on December 25, 2026."}],"balance_after":15051,"source":{"system":"sec-edgar","filing":"0001127602-21-031913","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221031913/form4.xml","form_type":"4"}},{"id":2458779,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-12-27T20:43:55.000Z","date":"2021-11-22","kind":"gift","acquired":false,"shares":182,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8280,"source":{"system":"sec-edgar","filing":"0001127602-21-031913","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221031913/form4.xml","form_type":"4"}},{"id":2608852,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-08-10T15:56:11.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":300,"price":409.4,"value":122820.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $409.10 to $409.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8462,"source":{"system":"sec-edgar","filing":"0001127602-21-023433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023433/form4.xml","form_type":"4"}},{"id":2608851,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-08-10T15:56:11.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":1042,"price":402.433,"value":419335.186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $402.25 to $402.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8762,"source":{"system":"sec-edgar","filing":"0001127602-21-023433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023433/form4.xml","form_type":"4"}},{"id":2608850,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-08-10T15:56:11.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":900,"price":401.664,"value":361497.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $401.48 to $401.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9804,"source":{"system":"sec-edgar","filing":"0001127602-21-023433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023433/form4.xml","form_type":"4"}},{"id":2608849,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-08-10T15:56:11.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":1458,"price":400.907,"value":584522.406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $400.22 to $401.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10704,"source":{"system":"sec-edgar","filing":"0001127602-21-023433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023433/form4.xml","form_type":"4"}},{"id":2689446,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-01T22:03:31.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":3476,"price":337.99,"value":1174853.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 869 on May 28, 2022, 869 on May 28, 2023, 869 on May 28, 2024 and 869 on May 28, 2025."}],"balance_after":3476,"derivative":{"exercise_price":337.99,"exercise_date":"2022-05-28","expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":3476},"source":{"system":"sec-edgar","filing":"0001127602-21-018567","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018567/form4.xml","form_type":"4"}},{"id":2689445,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-06-01T22:03:31.000Z","date":"2021-05-29","kind":"tax_withholding","acquired":false,"shares":223,"price":337.99,"value":75371.77,"ownership":{"direct":true},"balance_after":12162,"source":{"system":"sec-edgar","filing":"0001127602-21-018567","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018567/form4.xml","form_type":"4"}},{"id":2689444,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-06-01T22:03:31.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":1124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 281 on May 28, 2022, 281 on May 28, 2023, 281 on May 28, 2024 and 281 on May 28, 2025."}],"balance_after":12385,"source":{"system":"sec-edgar","filing":"0001127602-21-018567","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018567/form4.xml","form_type":"4"}},{"id":2830206,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-26T21:51:37.000Z","date":"2021-02-25","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":743,"derivative":{"exercise_price":88.05,"exercise_date":"2018-02-24","expiration_date":"2022-02-24","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001127602-21-008123","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008123/form4.xml","form_type":"4"}},{"id":2830205,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-26T21:51:37.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":1422,"price":283.5046,"value":403143.5412,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $283.195 to $283.945. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11261,"source":{"system":"sec-edgar","filing":"0001127602-21-008123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008123/form4.xml","form_type":"4"}},{"id":2830204,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-26T21:51:37.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":967,"price":282.2659,"value":272951.1253,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $282.01 to $282.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12683,"source":{"system":"sec-edgar","filing":"0001127602-21-008123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008123/form4.xml","form_type":"4"}},{"id":2830203,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-26T21:51:37.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":4334,"price":281.4128,"value":1219643.0752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $281.01 to $282.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13650,"source":{"system":"sec-edgar","filing":"0001127602-21-008123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008123/form4.xml","form_type":"4"}},{"id":2830202,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-26T21:51:37.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":2012,"price":280.7541,"value":564877.2492,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $280.01 to $281.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17984,"source":{"system":"sec-edgar","filing":"0001127602-21-008123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008123/form4.xml","form_type":"4"}},{"id":2830201,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-26T21:51:37.000Z","date":"2021-02-25","kind":"exercise","acquired":true,"shares":2750,"price":88.05,"value":242137.5,"ownership":{"direct":true},"balance_after":19996,"source":{"system":"sec-edgar","filing":"0001127602-21-008123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008123/form4.xml","form_type":"4"}},{"id":2833300,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-25T20:27:18.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":322,"price":282.98,"value":91119.56,"ownership":{"direct":true},"balance_after":17246,"source":{"system":"sec-edgar","filing":"0001127602-21-007876","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007876/form4.xml","form_type":"4"}},{"id":2836351,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-24T15:42:03.000Z","date":"2021-02-23","kind":"tax_withholding","acquired":false,"shares":315,"price":283.59,"value":89330.85,"ownership":{"direct":true},"balance_after":17568,"source":{"system":"sec-edgar","filing":"0001127602-21-007517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007517/form4.xml","form_type":"4"}},{"id":2836350,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-24T15:42:03.000Z","date":"2021-02-22","kind":"tax_withholding","acquired":false,"shares":317,"price":289.55,"value":91787.35,"ownership":{"direct":true},"balance_after":17883,"source":{"system":"sec-edgar","filing":"0001127602-21-007517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007517/form4.xml","form_type":"4"}},{"id":2886408,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-02T16:46:00.000Z","date":"2021-01-29","kind":"tax_withholding","acquired":false,"shares":4708,"price":260.88,"value":1228223.04,"ownership":{"direct":true},"balance_after":18200,"source":{"system":"sec-edgar","filing":"0001127602-21-003434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221003434/form4.xml","form_type":"4"}},{"id":2886407,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-02T16:46:00.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":11862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 23, 2018."}],"balance_after":22908,"source":{"system":"sec-edgar","filing":"0001127602-21-003434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221003434/form4.xml","form_type":"4"}},{"id":2886406,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Common Stock","published_at":"2021-02-02T16:46:00.000Z","date":"2020-12-01","kind":"gift","acquired":false,"shares":310,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11046,"source":{"system":"sec-edgar","filing":"0001127602-21-003434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221003434/form4.xml","form_type":"4"}},{"id":2991288,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-05T16:46:19.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":3042,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9128,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":3042},"source":{"system":"sec-edgar","filing":"0001127602-20-028214","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220028214/form4.xml","form_type":"4"}},{"id":2991287,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-05T16:46:19.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":3205,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6409,"derivative":{"exercise_price":109.34,"exercise_date":"2019-02-23","expiration_date":"2023-02-23","underlying":"Common Stock","underlying_shares":3205},"source":{"system":"sec-edgar","filing":"0001127602-20-028214","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220028214/form4.xml","form_type":"4"}},{"id":2991286,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":24730,"kind":"person","name":"LaPlume Joseph W","position":1,"cik":"0001767215","reported_name":"LaPlume Joseph W","relationship":{"officer":true,"officer_title":"EVP, Corp Strategy & Develop"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-05T16:46:19.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":492,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3493,"derivative":{"exercise_price":88.05,"exercise_date":"2018-02-24","expiration_date":"2022-02-24","underlying":"Common Stock","underlying_shares":492},"source":{"system":"sec-edgar","filing":"0001127602-20-028214","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220028214/form4.xml","form_type":"4"}}],"next_cursor":"2020-11-05T16:46:19.000000Z,2991286"}